OTC : ECIA
-$0.02 (-30.42%)
OTC
Robert H. Fries
Medical - Instruments & Supplies
Healthcare
ECIA
23
US
USD
1.07
1.74
0.69
0.13
0.00
$5.78M
0.07
0.42
-1.64
-0.02
-$0.0483
-$719.08K
-5.60%
-5.60%
-20.14%
-9.46%
-1.40
0.20
0.20
2/5
0 Analysts
%
-7.48
3/9
$945.65K
$3.51M
$2.05M
-$278.88K
$1.83M
0.31
-9.89
1.74
-20.14%
-8.88%
-53.89%
-60.97%
171 days
| Name | Title |
|---|---|
| David W. Newton | Co-Founder |
| Robert H. Fries | Interim President, CEO & Director |
| Brandon Shepard | Vice President of Controller, Treasurer & Corporate Secretary |
| Jason Johnson | Vice President of Sales |
No votes yet today — be the first to share your view!
About Encision Inc. (OTC:ECIA) Stock
Encision Inc. (ECIA), established in 1991 and headquartered in Boulder, Colorado, operates as a medical device firm specializing in the development, manufacturing, and commercialization of proprietary surgical instruments for the U.S. market. The company's core offering revolves around its patented Active Electrode Monitoring (AEM) technology, featured in both surgical instruments and dedicated monitors. This innovative system significantly enhances patient safety and optimizes outcomes during laparoscopic surgical procedures. Encision's AEM instrument portfolio encompasses a diverse array of endo-mechanical tools, such as scissors, graspers, and dissectors, alongside specialized fixed-tip and suction-irrigation electrodes. Beyond these, the company supplies specialized handles designed fo ... r complex laparoscopic operations, characterized by their robust shafts and ergonomic designs. They also provide the AEM EndoShield 2 burn protection systems. Complementing these instruments, Encision markets its AEM monitor product line, essential for use in conjunction with its AEM instruments. Distribution of Encision's products occurs through a hybrid sales model, leveraging both direct company representatives and an established network of independent sales agents.
Encision Inc. Announces Start of Stock Trading
2026-07-14 10:45:00
BOULDER, CO / ACCESS Newswire / July 14, 2026 / Encision Inc. (OTC Pink:ECIA), a medical device company that owns patented Active Electrode Monitoring (AEM®) technology designed to prevent dangerous stray energy burns in minimally invasive surgery, today announced that trading in its common stock has started. Encision trades on the OTC Markets with the same symbol, ECIA.
Frequently Asked Questions
What is the current Encision Inc. (ECIA) stock price?
Encision Inc.(OTC:ECIA) stock price is $0.035 in the last trading session. During the trading session, ECIA stock reached the peak price of $0.4 while $0.0002 was the lowest point it dropped to. The percentage change in ECIA stock occurred in the recent session was --30.42% while the dollar amount for the price change in ECIA stock was -$0.02.
ECIA's industry and sector of operation?
The OTC listed ECIA is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
Who are the executives of ECIA?
David W. Newton
| Co-Founder
Robert H. Fries
| Interim President, CEO & Director
Brandon Shepard
| Vice President of Controller, Treasurer & Corporate Secretary
Jason Johnson
| Vice President of Sales
|
How many employees does ECIA have?
Number of ECIA employees currently stands at 23. ECIA operates from 6797 Winchester Circle, Boulder, CO 80301, US.
Link for ECIA official website?
Official Website of ECIA is: https://www.encision.com
How do I contact ECIA?
ECIA could be contacted at phone #303 444 2600 and can also be accessed through its website. ECIA operates from 6797 Winchester Circle, Boulder, CO 80301, US.
How many shares of ECIA are traded daily?
The average number of ECIA shares traded daily for last 3 months was 623.
What is the market cap of ECIA currently?
The market value of ECIA currently stands at $435.76K with its latest stock price at $0.035